We investigated the effects of a novel small-molecule JAK inhibitor (AZD1480) on IL-6/JAK signal transduction and its biological consequences on the human myeloma-derived cell lines U266 and Kms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback